Please use this identifier to cite or link to this item:
Title: Best practices on immunomodulators and biological agents for Ulcerative colitis and Crohn's disease in Asia.
Authors: Ooi, C. J.
Hilmi, I.
Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis
Leong, R. W. L.
Abdullah, M.
Simadibrata, M.
Rerknimitr, R.
De Silva, J. H.
Geary, R.
Ouyang, Q.
Yang, S. K.
Hisamatsu, T.
Limsrivilai, J.
Mustaffa, N.
Ong, E.
Wu, D. C.
Raja Ali, R. A.
Leung, W. K.
Lim, W. C.
Sollano, J.
Goh, K. L.
Ahuja, V.
Ong, D.
Ling, K. L.
Park, D. I.
Ye, B. D.
Ran, Z. H.
Chen, M. H.
Pisespongsa, P.
Makharia, G. K.
Wei, S. C.
Ng, S. C.
Chuah, S. W.
Banerjee, R.
Keywords: Crohn's disease
Issue Date: 2019
Publisher: Blackwell Scientific Publications
Citation: Journal of Gastroenterology and Hepatology.2019;[Epub ahead of print]
Abstract: The Asia Pacific Working Group on Inflammatory Bowel Disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology (APAGE) with the goal of improving IBD care in Asia. This consensus is carried out in collaboration with Asian Organization for Crohn's and Colitis (AOCC). With biological agents and biosimilars becoming more established, it is necessary to conduct a review on existing literature and establish a consensus on when and how to introduce biological agents and biosimilars in the conjunction with conventional treatments for ulcerative colitis (UC) and Crohn's disease (CD) in Asia. These statements also address how pharmacogenetics influence the treatments of UC and CD and provide guidance on response monitoring and strategies to restore loss of response. Finally, the review includes statements on how to manage treatment alongside possible Hepatitis B and tuberculosis infections, both common in Asia. These statements have been prepared and voted upon by members of IBD workgroup employing the modified Delphi process. These statements do not intend to be all-encompassing and future revisions are likely as new data continue to emerge.
Description: Indexed in Medline
ISSN: 0815-9319 (Print)
1440-1746 (Electronic)
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
Ooi_et_al-2019-Journal_of_Gastroenterology_and_Hepatology.pdf1.03 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.